Literature DB >> 16775340

Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.

Neelam Sharma-Walia1, Hari Raghu, Sathish Sadagopan, Ramu Sivakumar, Mohanan Valiya Veettil, Pramod P Naranatt, Marilyn M Smith, Bala Chandran.   

Abstract

Infection of human dermal microvascular endothelial (HMVEC-d) cells and human foreskin fibroblast (HFF) cells in vitro by Kaposi's sarcoma-associated herpesvirus (KSHV) provides an excellent in vitro model system to study viral latency. KSHV infection is characterized by the induction of preexisting host signal cascades; sustained expression of the latency-associated open reading frame 73 (ORF73) (LANA-1), ORF72, and K13 genes; transient expression of a limited number of lytic genes, including the lytic cycle switch ORF50 (replication and transcription activator) gene; and reprogramming of host transcriptional machinery regulating a variety of cellular processes, including several proinflammatory responses. The cyclooxygenase 2 (COX-2) gene was one of the host cell genes that was highly up-regulated at 2 and 4 h postinfection (p.i.) of HMVEC-d and HFF cells (P. P. Naranatt, H. H. Krishnan, S. R. Svojanovsky, C. Bloomer, S. Mathur, and B. Chandran, Cancer Res. 64:72-84, 2004). Since COX-2 is an important mediator of inflammatory and angiogenic responses, here, using real-time PCR, Western blot, and immunofluorescence assays, we characterized the COX-2 stimulation and its role in KSHV infection. KSHV induced a robust COX-2 expression, which reached a maximum at 2 h p.i. in HMVEC-d cells and at 8 h p.i. in HFF cells, and significantly higher levels were continuously detected for up to 72 h p.i. Constitutive COX-1 protein levels were not modulated by KSHV infection. Moderate levels of COX-2 were also induced by UV-irradiated KSHV and by envelope glycoproteins gB and gpK8.1A; however, viral gene expression appears to be essential for the increased COX-2 induction. High levels of prostaglandin E(2) (PGE(2)), a COX-2 product, were released in the culture supernatant medium of infected cells. PGE(2) synthase, catalyzing the biosynthesis of PGE(2), also increased upon infection and inhibition of COX-2 by NS-398, and indomethacin drastically reduced the levels of PGE(2) and PGE(2) synthase. COX-2 inhibition did not affect KSHV binding, internalization of virus, or the trafficking to the infected cell nuclei. However, latent ORF73 gene expression and ORF73 promoter activity were significantly reduced by COX-2 inhibitors, and this inhibition was relieved by exogenous supplementation with PGE(2). In contrast, lytic ORF50 gene expression and ORF50 promoter activity were unaffected. These studies demonstrate that COX-2 and PGE(2) play roles in facilitating latent viral gene expression and the establishment and maintenance of latency and suggest that KSHV has evolved to utilize the inflammatory responses induced during infection of endothelial cells for the maintenance of viral latent gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775340      PMCID: PMC1488986          DOI: 10.1128/JVI.00231-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections.

Authors:  M Wachsman; L Aurelian; J W Burnett
Journal:  Br J Dermatol       Date:  1990-09       Impact factor: 9.302

Review 2.  The role and regulation of COX-2 during viral infection.

Authors:  Sarah A Steer; John A Corbett
Journal:  Viral Immunol       Date:  2003       Impact factor: 2.257

3.  Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection.

Authors:  Pramod P Naranatt; Harinivas H Krishnan; Stan R Svojanovsky; Clark Bloomer; Sachin Mathur; Bala Chandran
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

4.  Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.

Authors:  Harinivas H Krishnan; Pramod P Naranatt; Marilyn S Smith; Ling Zeng; Clark Bloomer; Bala Chandran
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  Transcriptional response of a common permissive cell type to infection by two diverse alphaherpesviruses.

Authors:  Neelanjana Ray; L W Enquist
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

Authors:  Corey Casper; W Garrett Nichols; Meei-Li Huang; Lawrence Corey; Anna Wald
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

7.  Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes.

Authors:  A Henke; H P Spengler; A Stelzner; M Nain; D Gemsa
Journal:  Res Immunol       Date:  1992-01

8.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements.

Authors:  Neelam Sharma-Walia; Pramod P Naranatt; Harinivas H Krishnan; Ling Zeng; Bala Chandran
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  The effect of indomethacin, prostaglandin E2 and interferon on the multiplication of herpes simplex virus type 1 in human lymphoid cells.

Authors:  M Khyatti; J Menezes
Journal:  Antiviral Res       Date:  1990-09       Impact factor: 5.970

Review 10.  Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.

Authors:  Curzio Rüegg; Olivier Dormond; Agnese Mariotti
Journal:  Biochim Biophys Acta       Date:  2004-03-04
View more
  47 in total

Review 1.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

2.  Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.

Authors:  Olsi Gjyshi; Arunava Roy; Sujoy Dutta; Mohanan Valiya Veettil; Dipanjan Dutta; Bala Chandran
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

3.  Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen.

Authors:  Arun George Paul; Neelam Sharma-Walia; Nagaraj Kerur; Carl White; Bala Chandran
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

4.  Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.

Authors:  Vivek Vikram Singh; Nagaraj Kerur; Virginie Bottero; Sujoy Dutta; Sayan Chakraborty; Mairaj Ahmed Ansari; Nitika Paudel; Leela Chikoti; Bala Chandran
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 5.  Inflammatory stress and sarcomagenesis: a vicious interplay.

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2013-08-27       Impact factor: 3.667

6.  Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-03-20       Impact factor: 7.012

7.  Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells.

Authors:  Vasu Punj; Hittu Matta; Sandra Schamus; Preet M Chaudhary
Journal:  BMC Med Genomics       Date:  2009-08-06       Impact factor: 3.063

8.  Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.

Authors:  Sathish Sadagopan; Neelam Sharma-Walia; Mohanan Valiya Veettil; Hari Raghu; Ramu Sivakumar; Virginie Bottero; Bala Chandran
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  Phosphorylation of Kaposi's sarcoma-associated herpesvirus processivity factor ORF59 by a viral kinase modulates its ability to associate with RTA and oriLyt.

Authors:  Maria E McDowell; Pravinkumar Purushothaman; Cyprian C Rossetto; Gregory S Pari; Subhash C Verma
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  Overexpression of xCT induces up-regulation of 14-3-3beta in Kaposi's sarcoma.

Authors:  Yan Zeng; Yan Li; Ri-Sheng Chen; Xin He; Lei Yang; Wei Li
Journal:  Biosci Rep       Date:  2010-03-25       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.